The Global Fund Board has approved $57.9 million to finance interventions listed on the Register of Unfunded Quality Demand (UQD) for existing grants in five countries: Algeria (HIV), Ethiopia (TB), Ghana (malaria), Nigeria (TB), and Uzbekistan (TB) grants. The additional funding comes from the reallocation of unutilized funds from other existing Global Fund grants to other countries, termed ‘portfolio optimization’.
You are here
Unfunded quality demand
Global Fund Board approves additional funding worth $57.9 million through portfolio optimization, for grants in five countries
Global Fund has allocated an additional $43.3 million to existing grants in several countries for 'portfolio optimization'
As of 1 July 2019, the Technical Review Panel (TRP) has completed its reviews of funding requests for the 2017-2019 allocations and has issued recommendations covering all of the funds available for country allocation ($10.3 billion); all of the matching funds that were subject to TRP review ($313 million); and all of the funds earmarked for multi-country grants ($260 million).
On 16 August 2019, by electronic vote, the Global Fund Board approved funding for three country grants worth $32.7 million (Colombia HIV, Honduras TB/HIV and Kazakhstan TB). Domestic commitments for the programs included in the approved country grants amounted to $1.17 billion. Initiatives valued at $2.4 million were added to the Unfunded Quality Demand (UQD) Register. (See Table 1.)
On 24 July 2019, the Global Fund Board approved funding in the amount of $18.0 million from the 2017-2019 allocations for several interventions on the Unfunded Quality Demand (UQD) Register. The funds will be added to three existing country grants and one existing multi-country grant. The sources of these funds are portfolio optimization and a private sector contribution. (See Table 1 below.)
The Global Fund describes the $41.6 million in funding awarded to India in April as an innovative approach that will catalyze significant additional funding for the fight against tuberculosis. The award includes $40.0 million to buy down a portion of a $400.0-million loan from the World Bank over five years.
Global Fund Board approves new country and multi-country grants along with interventions on UQD Register
On 13 May 2019, the Global Fund Board approved, by electronic vote, funding for five country grants having a total value of $25.2 million. Domestic commitments for the programs included in the approved country grants amounted to $937.9 million. The five country grants were for four countries: Gabon, Georgia, Peru and Serbia. The largest award ($9.3 million) was for a Georgia HIV grant. (See Table 1 for details.)
On 22 March 2019, the Global Fund Board approved funding for two country grants and supplementary funding for a third –– for a total value of $11.0 million. Interventions worth $4.1 million were added to the Unfunded Quality Demand (UQD) Register. Domestic commitments for the programs included in the approved country grants amounted to $28.5 million. (See Table 1 for details.)